Finance
Barclays reiterates Overweight on BridgeBio Pharma stock at $157
Barclays reiterates Overweight on BridgeBio Pharma stock at $157
I
Investing.com
April 28, 2026·1 min read
GM
FinanceBarclays reiterates Overweight on BridgeBio Pharma stock at $157
Original article
Barclays reiterates Overweight on BridgeBio Pharma stock at $157
Published by Investing.com